Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Current Hematologic Malignancy Reports|August 19, 2022
Novel Therapies in Myelofibrosis: Beyond JAK InhibitorsJulian A Waksal, John MascarenhasLeukemia & Lymphoma|February 5, 2021
Incorporation of Novel therapies for the treatment of acute myeloid leukemia: a perspectiveJulian A Waksal, Martin S TallmanBest Practice & Research. Clinical Haematology|November 4, 2022
Contemporary and future strategies in polycythemia veraJulian A Waksal, Douglas A TremblayOncotargets and Therapy|August 30, 2021
Clinical Utility of Fedratinib in MyelofibrosisJulian A Waksal, Douglas Tremblay, John MascarenhasLeukemia & Lymphoma|December 2, 2021
Novel therapeutics and targets in myelofibrosisJulian A Waksal, Claire N Harrison, John O MascarenhasClinical Advances in Hematology & Oncology : H&O|January 31, 2024
Risk factors for disease progression and treatment goals in polycythemia veraJulian A Waksal, Nicole E Wagner, John O MascarenhasTherapeutic Advances in Hematology|August 11, 2023
Treating accelerated and blast phase myeloproliferative neoplasms: progress and challengesHelen O Ajufo, Julian A Waksal, John O Mascarenhas, et al.Leukemia|April 10, 2024
Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemiaHarry Fruchtman, Zachary M Avigan, Julian A Waksal, et al.Blood Advances|May 22, 2023
Telomerase-targeted therapies in myeloid malignanciesJulian A Waksal, Claudia Bruedigam, Rami S Komrokji, et al.Leukemia & Lymphoma|May 18, 2026
Long term outcomes of idasanutlin therapy in hydroxyurea-refractory polycythemia vera patientsMegan Metzger, Julian A Waksal, Jayanshu Jain, et al.Pageof 2